Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice
Nutrients · 03.01.2023 · 15 (1) · 246
DOI: 10.3390/nu15010246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 03.01.2023. Verfasst von Narongsuk Munkong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, University of Phayao, Phayao 56000, Thailand. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Oryza, Dyslipidemias. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation Fund, University of Phayao, Thailand, Research Group in Exercise and Aging-Associated Diseases, Faculty of Medicine, Thammasat University, Thailand.
Abstract (Originalsprache)
Red rice bran extract (RRBE) is rich in phytonutrients and has been shown to have anti-diabetic, anti-inflammatory, and antioxidant properties. However, its anti-hepatic steatosis and anti-dyslipidemic properties have not been thoroughly investigated. This study examined the aforementioned properties of RRBE, the underlying mechanism by which it alleviated non-alcoholic fatty liver disease in high-fat diet (HFD)-fed mice, and its major bioactive constituents. The mice were divided into four groups based on their diet: (1) low-fat diet (LFD), (2) LFD with high-dose RRBE (1 g/kg/day), (3) HFD, and (4) HFD with three different doses of RRBE (0.25, 0.5, and 1 g/kg/day). The administration of RRBE, especially at medium and high doses, significantly mitigated HFD-induced hepatosteatosis and concomitantly improved the serum lipid profile. Further, RRBE modified the level of expression of lipid metabolism-related genes (adipose triglyceride lipase (ATGL), cluster of differentiation 36 (CD36), lipoprotein lipase (LPL), liver X receptor alpha (LXRα), sterol regulatory element-binding protein-1c (SREBP-1c), SREBP-2, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), and carnitine palmitoyltransferase 1A (CPT1A)) in hepatic or adipose tissues and improved the expression of hepatic high-density lipoprotein cholesterol (HDL-C) cmetabolism-related genes (hepatic lipase (HL) and apolipoprotein A-ǀ (ApoA-ǀ)). RRBE also attenuated markers of liver injury, inflammation, and oxidative stress, accompanied by a modulated expression of inflammatory (nuclear factor-kappa B (NF-κB) and inducible nitric oxide synthase (iNOS)), pro-oxidant (p47phox), and apoptotic (B-cell lymphoma protein 2 (Bcl-2)-associated X and Bcl-2) genes in the liver. High-performance liquid chromatography analyses indicated the presence of protocatechuic acid, γ-oryzanol, vitamin E, and coenzyme Q10 in RRBE. Our data indicate that RRBE alleviates HFD-induced hepatosteatosis, dyslipidemia, and their pathologic complications in part by regulating the expression of key genes involved in lipid metabolism, inflammation, oxidative stress, and apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, University of Phayao, Phayao 56000, Thailand.
- Division of Nutrition for Health and Sport, Department of Sport and Health Sciences, Faculty of Sport Science, Kasetsart University, Nakhon Pathom 73140, Thailand.
- Applied Thai Traditional Medicine Program, School of Public Health, University of Phayao, Phayao 56000, Thailand.
- Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
- Agriculture Program, School of Agriculture and Natural Resources, University of Phayao, Phayao 56000, Thailand.
- Division of Physiology, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
ORCID-Profile: Narongsuk Munkong, Nattanida Jantarach, Bhornprom Yoysungnoen
Förderung
- Thailand Science Research and Innovation Fund
- University of Phayao, Thailand
- Research Group in Exercise and Aging-Associated Diseases, Faculty of Medicine, Thammasat University, Thailand
Zitieren
APA
Munkong, N., Somnuk, S., Jantarach, N., Ruxsanawet, K., Nuntaboon, P., Kanjoo, V., & Yoysungnoen, B. (2023). Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients, 15(1), 246. https://doi.org/10.3390/nu15010246
Vancouver
Munkong N, Somnuk S, Jantarach N, Ruxsanawet K, Nuntaboon P, Kanjoo V, et al. Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients. 2023;15(1):246. doi:10.3390/nu15010246
BibTeX
@article{Munkong2023,
author = {Munkong, Narongsuk and Somnuk, Surasawadee and Jantarach, Nattanida and Ruxsanawet, Kingkarnonk and Nuntaboon, Piyawan and Kanjoo, Vaiphot and Yoysungnoen, Bhornprom},
title = {Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {1},
pages = {246},
doi = {10.3390/nu15010246}
}
EUVIMED